Your search returned 5 results.

Results
	1.	Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure. [electronic resource] by Chow, Chi-Kin Allan, Barrett W Chai, Qing Atwell, Shane Lu, Jirong Producer: 20161213 In: Molecular pharmaceutics vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A. [electronic resource] by Liu, Ling Lu, Jirong Allan, Barrett W Tang, Ying Tetreault, Jonathan Chow, Chi-Kin Barmettler, Barbra Nelson, James Bina, Holly Huang, Lihua Wroblewski, Victor J Kikly, Kristine Producer: 20160504 In: Journal of inflammation research vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. [electronic resource] by Bowles, Julie A Wang, Siao-Yi Link, Brian K Allan, Barrett Beuerlein, Gregory Campbell, Mary-Ann Marquis, David Ondek, Brian Wooldridge, James E Smith, Brian J Breitmeyer, James B Weiner, George J Producer: 20061102 In: Blood vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma. [electronic resource] by Forero-Torres, Andres de Vos, Sven Pohlman, Brad L Pashkevich, Maksim Cronier, Damien M Dang, Nam H Carpenter, Susan P Allan, Barrett W Nelson, James G Slapak, Christopher A Smith, Mitchell R Link, Brian K Wooldridge, James E Ganjoo, Kristen N Producer: 20120626 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. [electronic resource] by Benschop, Robert J Chow, Chi-Kin Tian, Yu Nelson, James Barmettler, Barbra Atwell, Shane Clawson, David Chai, Qing Jones, Bryan Fitchett, Jon Torgerson, Stacy Ji, Yan Bina, Holly Hu, Ningjie Ghanem, Mahmoud Manetta, Joseph Wroblewski, Victor J Lu, Jirong Allan, Barrett W Producer: 20200130 In: mAbs vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)